Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating gingivitis and preparation method thereof

A composition and technology of gingivitis, applied in the field of pharmaceutical composition for treating gingivitis and its preparation, can solve problems such as drug resistance and bacterial flora imbalance, achieve remarkable effect and improve the effect of immune regulation

Pending Publication Date: 2022-08-02
漳州无极药业有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, most of the various periodontal topical dosage forms are mainly antibacterial and bactericidal preparations, or some biofilm preparations can only promote the regeneration of gingival tissue, but may lead to adverse consequences such as bacterial imbalance and drug resistance. , people expect an ideal natural medicine that has anti-inflammatory and antibacterial effects, can regulate the oral micro-ecological balance, and promote the regeneration and repair of gingival tissue

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A pharmaceutical composition for treating gingivitis, comprising aconite, dandelion, honeysuckle, peppermint, isatidis, paeonol and magnolia.

[0026] Further, the components by weight of the medicinal materials in the pharmaceutical composition are: 6 parts of aconite, 20 parts of dandelion, 20 parts of honeysuckle, 20 parts of mint, 10 parts of isatidis, 15 parts of paeonol and Magnolia officinalis.

[0027] Further, the pharmaceutical composition further comprises: Scutellaria baicalensis, Ophiopogon japonicus, chrysanthemum, red peony root, Asparagus, Angelica dahurica and Salvia miltiorrhiza.

[0028] Further, the parts by weight of the medicinal materials in the pharmaceutical composition are: 12 parts of Scutellaria baicalensis, 5 parts of Ophiopogon japonicus, 8 parts of chrysanthemum, 5 parts of red peony root, 5 parts of Asparagus, 3 parts of Angelica Radix and 3 parts of Salvia miltiorrhiza.

[0029] A pharmaceutical composition for the treatment of gingiviti...

Embodiment 2

[0042] A pharmaceutical composition for treating gingivitis, comprising aconite, dandelion, honeysuckle, peppermint, isatidis, paeonol and magnolia.

[0043] Further, the parts by weight of the medicinal materials in the pharmaceutical composition are: 8 parts of aconite, 22 parts of dandelion, 23 parts of honeysuckle, 21 parts of mint, 12 parts of isatidis, 18 parts of paeonol and Magnolia officinalis.

[0044] Further, the pharmaceutical composition further comprises: Scutellaria baicalensis, Ophiopogon japonicus, chrysanthemum, red peony root, Asparagus, Angelica dahurica and Salvia miltiorrhiza.

[0045] Further, the parts by weight of the medicinal materials in the pharmaceutical composition are: 13 parts of Scutellaria baicalensis, 7 parts of Ophiopogon japonicus, 11 parts of chrysanthemum, 6 parts of red peony root, 7 parts of Asparagus, 4 parts of Angelica Radix and 4 parts of Salvia miltiorrhiza.

[0046] A pharmaceutical composition for the treatment of gingivitis an...

Embodiment 3

[0059] A pharmaceutical composition for treating gingivitis, comprising aconite, dandelion, honeysuckle, peppermint, isatidis, paeonol and Magnolia.

[0060] Further, the parts by weight of the medicinal materials in the pharmaceutical composition are: 9 parts of aconite, 25 parts of dandelion, 25 parts of honeysuckle, 25 parts of mint, 15 parts of isatidis, 20 parts of paeonol and Magnolia officinalis.

[0061] Further, the pharmaceutical composition further includes: Scutellaria baicalensis, Ophiopogon japonicus, chrysanthemum, red peony root, Asparagus, Angelica dahurica and Salvia miltiorrhiza.

[0062] Further, the parts by weight of the medicinal materials in the pharmaceutical composition are: 15 parts of Scutellaria baicalensis, 9 parts of Ophiopogon japonicus, 12 parts of chrysanthemum, 8 parts of red peony root, 8 parts of Asparagus, 5 parts of Angelica dahurica and 5 parts of Salvia miltiorrhiza.

[0063] A pharmaceutical composition for the treatment of gingivitis ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating gingivitis. The pharmaceutical composition comprises radix aconiti carmichaeli, dandelion, honeysuckle, mint, radix isatidis, cortex moutan and cortex magnoliae officinalis. The pharmaceutical composition is prepared from pure natural traditional Chinese medicine components and has no side effect on a human body; honeysuckle, dandelion and mint in the traditional Chinese medicine extract have the effects of diminishing inflammation, resisting bacteria, relieving sore throat, promoting salivation, removing peculiar smell and the like, have the effects of inhibiting bacteria, diminishing inflammation and detoxifying, and have a remarkable effect on gingivitis; radix aconiti carmichaeli in the traditional Chinese medicine extracting solution has anti-inflammatory and analgesic effects; the cortex moutan contains paeonol, the cortex magnoliae officinalis contains magnolol, and both the paeonol and the magnolol have good anti-inflammatory and bacteriostatic effects; the radix isatidis has the effects of clearing away heat and toxic materials, and an extracting solution of the radix isatidis can effectively inhibit common cocci, typhoid fever and bacillus influenza and also can improve the immunoregulation effect.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a pharmaceutical composition for treating gingivitis and a preparation method thereof. Background technique [0002] In medicine, the soft tissue that surrounds and covers the teeth is called gingiva, and the acute and chronic inflammation that occurs in the gingival tissue is called gingivitis. It is mainly characterized by bleeding gums. Generally, it is easy to bleed when brushing, sucking and chewing hard objects. Bright red or purple, swollen or soft, shiny surface, local calculus, soft scale, plaque accumulation, erosion of the dominant gingival margin, a small amount of pus discharged from the gingival margin, and papilledema and deepening of the gingival sulcus may occur , and even the formation of gum abscesses. [0003] At present, most of the various periodontal local dosage forms are mainly bacteriostatic and bactericidal preparations,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/714A61K36/8968A61P1/02A61P29/00A61K8/9789A61K8/9794A61Q11/00
CPCA61K36/714A61K36/288A61K36/355A61K36/534A61K36/195A61K36/315A61K36/71A61K36/65A61K36/575A61K36/539A61K36/8968A61K36/287A61K36/8965A61K36/232A61K36/537A61K9/0095A61P1/02A61P29/00A61K8/9789A61K8/9794A61Q11/00A61K2236/33A61K2236/51A61K2236/53A61K2300/00Y02A50/30
Inventor 林聪明
Owner 漳州无极药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products